ACTR-49. PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: Tumor Treating Fields (TTFields) in combination with adjuvant temozolomide (TMZ), applied after completion of radiochemotherapy, showed significantly improved clinical outcome in newly diagnosed glioblastoma (GBM) patients in the EF-14 trial. In preclinical settings, TTFields synergistic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Glas, Martin, Scheffler, Björn, Lazaridis, Lazaros, Herrlinger, Ulrich, Pierscianek, Daniela, Sure, Ulrich, Proescholdt, Martin, Hau, Peter, Hense, Jörg, Kleinschnitz, Christoph, Grosu, Anca-Ligia, Stuschke, Martin, Kebir, Sied
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216409/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.081
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars